These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16363597)

  • 1. [Effect of probiotics on the prevention of diarrhea in Helicobacter pylori therapy].
    Nakajima S; Setoguchi Y; Yamamoto S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():539-42. PubMed ID: 16363597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adverse effects of Helicobacter pylori eradication and its prevention].
    Zhang S; Yanaka A
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():414-7. PubMed ID: 16363570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of interleukin-1beta genetic polymorphism on H. pylori eradication therapy].
    Take S; Mizuno M; Ishiki K
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():573-6. PubMed ID: 16363604
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
    Kobayashi K; Fujishiro M; Omata M; Oka M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():459-60. PubMed ID: 16363578
    [No Abstract]   [Full Text] [Related]  

  • 5. [How to eradicate Helicobacter pylori?].
    Cayla R
    Gastroenterol Clin Biol; 1996 Jan; 20(1 Pt 2):S119-S130. PubMed ID: 8734380
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.
    Cremonini F; Di Caro S; Covino M; Armuzzi A; Gabrielli M; Santarelli L; Nista EC; Cammarota G; Gasbarrini G; Gasbarrini A
    Am J Gastroenterol; 2002 Nov; 97(11):2744-9. PubMed ID: 12425542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PPI plus bismuth-based quintuple therapy].
    Kimura K; Hiratsuka T; Tamura K; Hiratsuka H; Suzuki T; Bray R
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():452-8. PubMed ID: 16363577
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment.
    Szajewska H; Horvath A; Piwowarczyk A
    Aliment Pharmacol Ther; 2010 Nov; 32(9):1069-79. PubMed ID: 21039671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
    Iwasaki A
    Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
    Shimizu N; Kubota K; Kaminishi M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():478-81. PubMed ID: 16363583
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
    Kagaya H; Kato M; Asaka M
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():455-9. PubMed ID: 11979827
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adverse effects of H. pylori eradication therapy and its measure].
    Miwa H; Kurosawa A; Sato N
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():467-70. PubMed ID: 11979829
    [No Abstract]   [Full Text] [Related]  

  • 14. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
    Mitsuno Y; Yoshida H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():452-4. PubMed ID: 11979826
    [No Abstract]   [Full Text] [Related]  

  • 16. [New triple therapy for Helicobacter pylori infection].
    Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():414-9. PubMed ID: 11979817
    [No Abstract]   [Full Text] [Related]  

  • 17. [Eradication of Helicobacter pylori].
    Herszényi L
    Orv Hetil; 2003 Oct; 144(40):1991-2. PubMed ID: 14626641
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
    Sugano K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():627-31. PubMed ID: 11979859
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-Helicobacter pylori quadruple therapy].
    Fukuda Y; Sakagami T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():442-51. PubMed ID: 16363576
    [No Abstract]   [Full Text] [Related]  

  • 20. [Helicobacter pylori eradication therapy for children].
    Konno M
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():470-3. PubMed ID: 16363581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.